STRATA Skin Sciences (SSKN) Capital Expenditures (2010 - 2025)

STRATA Skin Sciences has disclosed Capital Expenditures across 14 years of filings, most recently posting $1.4 million for Q4 2025.

• Capital Expenditures for Q4 2025 came in at $1.4 million, down 16.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (down 10.27% YoY), and the FY2025 annual result was $1.5 million, down 10.27% from the prior year.
• Capital Expenditures came in at $1.4 million for Q4 2025 at STRATA Skin Sciences, up from -$40000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.8 million in Q1 2023 to a low of -$1.1 million in Q3 2024.
• The 5-year median for Capital Expenditures is $733000.0 (2021), against an average of $775600.0.
• Across the five-year window, Capital Expenditures surged 163.92% in 2023 and plunged 451.55% in 2024, its largest moves.
• STRATA Skin Sciences' Capital Expenditures stood at $1.1 million in 2021, then surged by 50.35% to $1.7 million in 2022, then climbed by 1.12% to $1.7 million in 2023, then decreased by 4.77% to $1.6 million in 2024, then fell by 16.26% to $1.4 million in 2025.
• The last three Capital Expenditures figures came in at $1.4 million (Q4 2025), -$40000.0 (Q3 2025), and -$61000.0 (Q2 2025), per Business Quant data.